Clinical Trial Update: Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/Paclitaxel [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating Ombrabulin in platinum-sensitive recurrent ovarian cancer patients treated with carboplatin and paclitaxel. The study has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Ombrabulin (ombrabulin)

Snippet

Sponsor: Sanofi | Conditions: Ovarian Cancer Recurrent | Phase 2 | Status: COMPLETED